The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Alliance A071701: Genomically guided treatment trial in brain metastases.
 
Priscilla Kaliopi Brastianos
Honoraria - Angiochem; Genentech; Merck
Consulting or Advisory Role - Angiochem; ElevateBio; Genentech/Roche; Lilly; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Lilly; Merck; Pfizer
 
Erin Twohy
No Relationships to Disclose
 
Carey K. Anders
Honoraria - Eisai; Genentech/Roche; IPSEN; Puma Biotechnology; Seagen
Consulting or Advisory Role - Eisai; Genentech/Roche; Ipsen; Puma Biotechnology; Seagen
Research Funding - G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai
 
A. John Iafrate
Stock and Other Ownership Interests - Archer
Consulting or Advisory Role - Chugai Pharma; Debiopharm Group; Repare Therapeutics; Repare Therapeutics; Roche
Research Funding - Sanofi; Sanofi
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Macrogenics; Merck; Pfizer; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly; Teva
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly; Macrogenics; Polyphor
 
Justine Vanessa Cohen
Consulting or Advisory Role - Bristol-Myers Squibb; Genzyme
 
Rebecca Suk Heist
Honoraria - Chugai/Roche
Consulting or Advisory Role - Apollomics; Boehringer Ingelheim; Novartis; Tarveda Therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); Exelixis (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst); Turning Point Therapeutics (Inst)
 
Elizabeth Robins Gerstner
Consulting or Advisory Role - Array BioPharma (I); Blue Earth Diagnostics; MyoKardia (I)
 
Timothy J. Kaufmann
No Relationships to Disclose
 
Susan Geyer
No Relationships to Disclose
 
Laura Hoffman
No Relationships to Disclose
 
Priya Kumthekar
Leadership - Vivacitas Oncology
Stock and Other Ownership Interests - Vivacitas Oncology
Consulting or Advisory Role - Abbvie; Orbus Therapeutics
Research Funding - Abbvie; DNAtrix; Genentech/Roche; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Frederick G. Barker
No Relationships to Disclose
 
Scott L. Carter
No Relationships to Disclose
 
Paul D. Brown
Honoraria - UpToDate
 
Evanthia Galanis
Consulting or Advisory Role - Abbvie (Inst); Celgene; Genentech/Roche (Inst); Karyopharm Therapeutics (Inst); KIYATEC; Oncorus
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); TRACON Pharma (Inst)